Genoptix

Genoptix

Provides specialized oncology diagnostics services. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$7.7m

Series B
N/A

$3.0m

Series C
N/A

$17.3m

Series D
N/A

$85.0m

Valuation: $265m

IPO
*

N/A

Growth Equity VC

$470m

Valuation: $470m

Acquisition
Total Funding$28.0m

Recent News about Genoptix

Edit
More about Genoptixinfo icon
Edit

Genoptix, headquartered in Carlsbad, California, specializes in oncology diagnostic testing services. The company primarily serves physicians and patients in the fight against cancer by providing advanced diagnostic tools and expert analysis. Genoptix operates in the healthcare sector, focusing on hematology and oncology diagnostics. The core service offered is flow cytometry, a technique that uses advanced instruments and laser technology to measure properties of cells and detect cancer cells in samples of bone marrow, blood, or lymph nodes. This process involves treating samples with fluorescent antibodies and scanning them with a laser beam to provide accurate diagnoses.

Genoptix boasts one of the largest teams of board-certified experts in one location, ensuring insightful and timely diagnoses for even the most challenging cases. The company operates a laboratory that is open six days a week and offers after-hours assistance through on-duty Client Services Representatives. Genoptix also provides direct billing to established clients such as hospitals and offers a secure web portal for online invoice review and payment. The company simplifies the billing process with a dedicated team of specialists to assist healthcare professionals and patients with insurance coverage, Medicare coding, and payment options. Additionally, Genoptix handles third-party billing for commercial insurance companies, provided that complete and accurate information is submitted on the test requisition form.

Keywords: oncology, diagnostic testing, flow cytometry, cancer detection, hematology, board-certified experts, direct billing, secure web portal, Medicare coding, third-party billing.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Genoptix

Edit
HistoRx
ACQUISITION by Genoptix Sep 2012
Rosetta Genomics
ACQUISITION by Genoptix Dec 2017